[Physiopathology and genetics of epilepsy: recent data].

Biol Aujourdhui 2011 19;205(1):29-31. Epub 2011 Apr 19.

Sanofi-Aventis R&D, 13 quai Jules Guesde, 94403 Vitry-sur-Seine, France.

Novel strategies are needed to treat epilepsy, in order to ensure efficiency, security and prevention. The search for innovating anti-epileptics is based on finding appropriate target molecules, among which the most pertinent appear to be chlore and potassium channels. Transcriptomics and proteomics are also prone to detect genes or proteins implicated in the disease, in particular when biopsies from healthy and epileptic brains are compared. Animal genetic models provide information about epilepsies with a unique origin. Finally some targets are identified through fortuitous findings from research in other fields, notably that of pro-inflammatory cytokines.

Download full-text PDF

Source
http://dx.doi.org/10.1051/jbio/2011003DOI Listing
August 2011

Publication Analysis

Top Keywords

genes proteins
4
detect genes
4
prone detect
4
proteins implicated
4
implicated disease
4
healthy epileptic
4
biopsies healthy
4
disease biopsies
4
proteomics prone
4
channels transcriptomics
4
molecules pertinent
4
target molecules
4
appropriate target
4
pertinent appear
4
appear chlore
4
potassium channels
4
chlore potassium
4
epileptic brains
4
brains compared
4
fortuitous findings
4

Similar Publications